Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Nemluvio Galderma Australia Pty Ltd
Product name
Nemluvio
Sponsor
Accepted date
May-2024
Active ingredients
nemolizumab
Proposed indication
For the treatment of moderate-to-severe atopic dermatitis.
Application type
A (new medicine)
Publication date
May-2024